4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026380
Options or other derivatives
- Chief Compliance Officer acquired 128,202 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pommer Jerry Lynn · Chief Compliance Officer
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-22 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +69,793 | 69,793 | D |
| 2021-10-22 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +14,540 | 14,540 | D |
| 2021-10-22 | Grant or award : show line 3 in the form Employee Stock Option (right to buy) | +6,979 | 6,979 | D |
| 2021-10-22 | Grant or award : show line 4 in the form Earnout Rights (Restricted Stock Units) | +36,890 | 36,890 | D |
Loading xslF345X03/ownership.xml…